Evidence map›Paper›PMID 35761872›Full record

ArticleOxidative medicine and cellular longevity2022

A

Jinquan Chen, Long Zhao, Xuanheng Ding, Yan Wen, Lingda Wang, Qinxin Shu, Wenxi Xie, Yanyao Liu, H Peng

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Innate immune biology in age-related macular degeneration.Frontiers in cell and developmental biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jinquan ChenDepartment of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Long ZhaoDepartment of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xuanheng DingDepartment of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yan WenDepartment of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lingda WangDepartment of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qinxin ShuDepartment of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wenxi XieDepartment of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yanyao LiuDepartment of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
H PengDepartment of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.ORCID https://orcid.org/0000-0003-4758-3752
The Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils participate in the advancement of the human innate immune system and respond to perceived endogenous and exogenous threats. As a response mechanism, neutrophil extracellular traps (NETs) form near pathogens and surrounding tissues during an immune response. Drusen is an important marker of Age-Related Macular Degeneration (AMD) and plays an important role in the course of AMD. A

Indexed as

Extracellular TrapsMacular DegenerationAnimalsHumansMiceNADPH OxidasesNeutrophilsToll-Like Receptor 4NADPH OxidasesTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID35761872
PMCPMC9233592
OpenAlexW4283066146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.